EU PHARMACEUTICALS ANAVAR 2.5

EU PHARMACEUTICALS EUROPE=ANAVAR 2.5(2.5MG OXANDROLONE/TAB=56 CAPS)

ANDROGENIC 24

ANABOLIC      322-630

Active-Life: 8-12 hours

Drug Class: Anabolic/Androgenic Steroid (Oral)

Average Reported Dosage: Men 20-50mg daily Women 10-15mg daily

Acne: Only when administered in high dosages

Water Retention: Rare

High Blood Pressure: Rare

Liver Toxic: Yes, c17-alfa-alkylated steroid. Due to low dosages toxicity is low-moderate

Aromatization: None

DHT conversion: Quite low

Decreases HPTA function: Unlikely even in high dosage use

Oxandrolone was often refereed to as an all purpose oral AAS. This drug was once marketed under the product name (still commonly used trade name) of Anavar. It has the unique quality of significantly stimulating (more than other AAS) the synthesis of phosphocreatine in muscle cells which in turn provides faster regeneration of, and a distinct elevation in, ATP. Of course all AAS have this effect to some extent. Oxandrolone is simply unmatched in this aspect.

(See Creatine for more info) Due to this quality, a rapid build- up in strength was frequently reported and an obvious distinct hardness in muscle was obtained with little weight gain and no aromatization.

Though it is a common belief that Oxandrolone is not very anabolic, a clinical study showed a 44% increase in muscle cell protein synthesis after only 5 days of administration. Since Oxandrolone does not aromatize to estrogen, water retention is reported as quite low and gyno was of no concern. Also, for the same reason, during dieting phases fat deposits were said to be “burned away” more quickly. (Especially when the drug was co-administered with Clenbuterol).

Oxandrolone was reported to stack well with so -called mass steroids such as testosterone or with high anabolic/moderate androgenic steroids such as Equipoise or Nandrolones. Persons over 40 have reported excellent results by stacking 15-25 mg of Oxandrolone daily with 200-400 mg of Deca.

A very hard pre-contest appearance has been achieved by males when stacked with Oxandrolone and Halotestin if a estrogen/progesterone receptor antagonist (*See Nolvadex) had been utilized as well. As I said: “all purpose” was commonly the term of choice.

The drug Oxandrolone was originally manufactured to be used by women to prevent osteoporosis and for children as a cure for stunted growth. The low androgenic quality prevents almost all virilization for women in dosages of 15-mg daily or less. And for the same reason does not cause closure of the epiphysial plates prematurely. An interesting note: Oxandrolone does not suppress any part of the HYPOTHALAMUS-PITUITARY-TESTES AXIS (HPTA). This means Oxandrolone by itself will not significantly suppress natural testosterone production. Therefore it was not uncommon for some athletes to report post-cycle HPTA regeneration protocols that included this drug. The result was prominent lean mass retention.

Adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in some individuals who, without definite pathophysiologic reasons, fail to gain or maintain normal weight; to offset protein catabolism associated with prolonged administration of corticosteroids; for relief of bone pain frequently accompanying osteoporosis.

Also used for Catabolic illness (eg, alcoholic liver disease, burn injury).